Prateek Gandiga is a Rheumatology/Immunology physician affiliated with Emory Healthcare. OpenAlex indexes 19 publications with 1,764 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1365 Clifton Rd NE Bldg A
Atlanta, GA 303222113
Telephone
404-778-3539Registry record last updated 21 Jul 2022.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Janssen Biotech, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
41.2%Folate Analog Metabolic Inhibitor18%Methotrexate88%Methotrexate Sodium6%Rasuvo6%Part D<11 patientsPurine Antimetabolite10.1%Azathioprine100%Part D≥33 patients+ 4 more classes in this area
Antiparasitic
18.2%Antimalarial18.2%Hydroxychloroquine Sulfate100%Part D≥64 patientsMetabolism & gastrointestinal
14.9%Corticosteroid13%Prednisone100%Part D≥58 patientsAminosalicylate1.9%Sulfasalazine Dr100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chimeric antigen receptor T-cell (CAR-T) therapy and other cellular immunotherapy treatments for idiopathic inflammatory myopathies
Best Practice & Research Clinical Rheumatology
2026 - Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials
Clinical and Experimental Rheumatology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Allan Levey, MD, PhD
Emory Healthcare
James Lah, MD, PhD
Emory Healthcare
William Blum, MD
Emory Healthcare
Mehmet Bilen, MD
Emory Healthcare
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”